6/17
04:19 pm
gnft
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH [Yahoo! Finance]
Neutral
Report
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH [Yahoo! Finance]
6/17
04:10 pm
gnft
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
Neutral
Report
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
6/10
05:28 pm
gnft
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis [Yahoo! Finance]
Low
Report
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis [Yahoo! Finance]
6/10
05:22 pm
gnft
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
Low
Report
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
6/10
05:00 pm
gnft
Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis [Financial Post (Toronto, Ontario, Canada)]
6/10
04:58 pm
gnft
Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis [Yahoo! Finance]
Low
Report
Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis [Yahoo! Finance]
6/6
08:02 am
gnft
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
5/29
04:24 pm
gnft
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 [Yahoo! Finance]
High
Report
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 [Yahoo! Finance]
5/29
04:10 pm
gnft
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
High
Report
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
5/22
12:05 pm
gnft
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
Neutral
Report
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
5/15
10:57 am
gnft
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
5/14
04:28 pm
gnft
GENFIT Reports First Quarter 2024 Financial Information [Yahoo! Finance]
Low
Report
GENFIT Reports First Quarter 2024 Financial Information [Yahoo! Finance]
5/14
04:10 pm
gnft
GENFIT Reports First Quarter 2024 Financial Information
Low
Report
GENFIT Reports First Quarter 2024 Financial Information
4/25
04:20 pm
gnft
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) [Yahoo! Finance]
Low
Report
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) [Yahoo! Finance]
4/25
04:10 pm
gnft
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
Low
Report
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
4/15
04:23 pm
gnft
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents [Yahoo! Finance]
Medium
Report
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents [Yahoo! Finance]
4/15
04:10 pm
gnft
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
Medium
Report
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
4/5
02:12 pm
gnft
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F [Yahoo! Finance]
Low
Report
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F [Yahoo! Finance]
4/5
02:00 pm
gnft
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
Low
Report
GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
4/5
08:34 am
gnft
Altice USA, Genfit, Brooge Energy among premarket losers' pack [Seeking Alpha]
Medium
Report
Altice USA, Genfit, Brooge Energy among premarket losers' pack [Seeking Alpha]
4/5
08:22 am
gnft
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Medium
Report
Genfit S.A. (NASDAQ: GNFT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
4/4
04:28 pm
gnft
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
4/4
04:10 pm
gnft
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
Low
Report
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update